Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DaVita's gross profit for the
three
months ended in Jun. 2026 was $1,162 Mil. DaVita's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was $4,533 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. DaVita's gross profit for the
three
months ended in Jun. 2026 was $1,162 Mil. DaVita's Revenue for the
three
months ended in Jun. 2026 was $3,554 Mil. Therefore, DaVita's Gross Margin % for the quarter that ended in Jun. 2026 was 32.70%.
DaVita had a gross margin of 32.70% for the quarter that ended in Jun. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of DaVita was 32.91%. The lowest was 28.14%. And the median was 30.72%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DaVita had a gross margin of 32.70% for the quarter that ended in Jun. 2026 => Competition eroding margins
DaVita Gross Profit Related Terms
DaVita Gross Profit Historical Data
* Premium members only.
The historical data trend for DaVita's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DaVita's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Gross Profit distribution charts can be found below:
* The bar in red indicates where DaVita's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,533 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
DaVita's Gross Margin % for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DaVita (DVA) has a Gross Profit of $4,533 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on DaVita and its competitors.
Is DaVita's Gross Profit too high?
DaVita's current Gross Profit is $4,533 Mil. Overall, DaVita has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Gross Profit compare to EHC and UHS?
DaVita's Gross Profit of $4,533 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on DaVita and its competitors. DaVita's current Gross Profit is $4,533 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (DVA) is currently considered Fairly Valued. The stock's GF Value™ is $195.60, compared to a current price of $181.55 — trading 7.2% below its estimated fair value. The current Gross Profit is $4,533 Mil. DaVita's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For DaVita (DVA), the current Gross Profit is $4,533 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be undervalued.
The current stock price of $181.55 is trading 7.2% below its estimated GF Value™ of $195.60.
GuruFocus considers DaVita to be Fairly Valued.
Key valuation signals for DVA:
Gross Profit: $4,533 Mil
GF Value™: $195.60 vs. price of $181.55 (7.2% below fair value)
No single metric tells the full story. See the DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
91GF Score
Get the complete analysis for DVA
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DVA has been successfully added to your 
